Literature DB >> 19867604

THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA.

A R Dochez1.   

Abstract

These experiments demonstrate that protective substances are usually present in the blood of patients recovering from lobar pneumonia. As a rule, the appearance of protective bodies in the blood, when demonstrable, coincides rather sharply with the period of critical fall in temperature and the disappearance of symptoms. These substances are not present in the blood in any measurable degree before the crisis, but afterward they may reach a considerable concentration. In certain instances, protective substances either become evident some time after the occurrence of the crisis, or cannot be demonstrated at any period of the disease. Experiments in which it is possible to test serum against an homologous strain of pneumococcus yield in the majority of cases evidence of the presence of protective bodies; whereas in those in which stock cultures are used, the serum, as a rule, shows no protection. The development of specific protective substances in the serum of patients with lobar pneumonia suggests that these bodies may play a part in the mechanism of recovery.

Entities:  

Year:  1912        PMID: 19867604      PMCID: PMC2124994          DOI: 10.1084/jem.16.5.665

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Remarks on THE SERUM TREATMENT OF PNEUMONIA.

Authors:  R L Cecil
Journal:  Br Med J       Date:  1932-10-08

2.  AGGLUTINATION PHENOMENA IN LOBAR PNEUMONIA.

Authors:  H T Chickering
Journal:  J Exp Med       Date:  1914-12-01       Impact factor: 14.307

3.  STUDIES ON EXPERIMENTAL PNEUMONIA : IV. RESULTS OF PROPHYLACTIC VACCINATION AGAINST PNEUMOCOCCUS PNEUMONIA IN MONKEYS.

Authors:  R L Cecil; F G Blake
Journal:  J Exp Med       Date:  1920-04-30       Impact factor: 14.307

4.  THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA.

Authors:  R Cole
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

5.  FACTORS INVOLVED IN THE PRODUCTION OF IMMUNITY WITH PNEUMOCOCCUS VACCINE : I. ACTIVE AND PASSIVE IMMUNITY DURING THE FIRST SEVEN DAYS AFTER INJECTION OF ANTIGEN.

Authors:  A L Barach
Journal:  J Exp Med       Date:  1928-06-30       Impact factor: 14.307

6.  Fred Neufeld and pneumococcal serotypes: foundations for the discovery of the transforming principle.

Authors:  Klaus Eichmann; Richard M Krause
Journal:  Cell Mol Life Sci       Date:  2013-05-21       Impact factor: 9.207

7.  CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

Authors:  T Francis; W S Tillett
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

8.  FACTORS INVOLVED IN THE PRODUCTION OF IMMUNITY WITH PNEUMOCOCCUS VACCINE : II. INDUCTION OF ACTIVE IMMUNITY DURING THE COURSE OF LOBAR PNEUMONIA.

Authors:  A L Barach
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

9.  IMMUNOLOGICAL STUDIES IN PNEUMONIA.

Authors:  R Weil; J C Torrey
Journal:  J Exp Med       Date:  1916-01-01       Impact factor: 14.307

10.  STUDIES ON EXPERIMENTAL PNEUMONIA : VI. ACTIVE IMMUNITY FOLLOWING EXPERIMENTAL PNEUMOCOCCUS PNEUMONIA IN MONKEYS.

Authors:  R L Cecil; F G Blake
Journal:  J Exp Med       Date:  1920-05-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.